BOSULIF is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Bosutinib Monohydrate.
| Product ID | 0069-0136_28ccd2f3-a7b1-44fa-8dab-cb6a88fffd27 |
| NDC | 0069-0136 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BOSULIF |
| Generic Name | Bosutinib Monohydrate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-09-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA203341 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | BOSUTINIB MONOHYDRATE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2012-09-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA203341 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-09-04 |
| Ingredient | Strength |
|---|---|
| BOSUTINIB MONOHYDRATE | 500 mg/1 |
| SPL SET ID: | adc84ad5-a04d-4fee-9ba8-91f7abd928e3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-0135 | BOSULIF | Bosutinib monohydrate |
| 0069-0136 | BOSULIF | Bosutinib monohydrate |
| 0069-0193 | BOSULIF | Bosutinib monohydrate |
| 63539-117 | BOSULIF | Bosutinib |
| 63539-193 | BOSULIF | Bosutinib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BOSULIF 85254857 4292873 Live/Registered |
Wyeth LLC 2011-03-01 |
![]() BOSULIF 77813503 3971238 Live/Registered |
WYETH LLC 2009-08-26 |